AVROBIO Financials

AVROBIO Stock Summary

AVROBIO competes with Ocean Biomedical, Enveric Biosciences, Elevation Oncology, Zura Bio, and Hepion Pharmaceuticals. AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

AVROBIO Key Financial Ratios

AVROBIO Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AVROBIO's current stock value. Our valuation model uses many indicators to compare AVROBIO value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AVROBIO competition to find correlations between indicators driving AVROBIO's intrinsic value. More Info.AVROBIO is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AVROBIO's earnings, one of the primary drivers of an investment's value.

AVROBIO Market Pulse

Along with financial statement analysis, the daily predictive indicators of AVROBIO help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AVROBIO. We use our internally-developed statistical techniques to arrive at the intrinsic value of AVROBIO based on widely used predictive technical indicators. In general, we focus on analyzing AVROBIO Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AVROBIO's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.